SOPHiA GENETICS SA
SOPH
$3.07
-$0.05-1.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.78M | 17.73M | 15.85M | 15.81M | 15.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.78M | 17.73M | 15.85M | 15.81M | 15.78M |
| Cost of Revenue | 5.57M | 5.63M | 5.20M | 5.03M | 5.37M |
| Gross Profit | 12.21M | 12.10M | 10.65M | 10.78M | 10.41M |
| SG&A Expenses | 19.13M | 20.52M | 18.19M | 17.84M | 19.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -8.00K | -116.00K | -43.00K | -18.00K | -6.00K |
| Total Operating Expenses | 33.82M | 35.18M | 31.22M | 30.81M | 34.54M |
| Operating Income | -16.04M | -17.44M | -15.36M | -15.01M | -18.76M |
| Income Before Tax | -16.88M | -14.54M | -18.31M | -15.03M | -13.39M |
| Income Tax Expenses | 503.00K | 616.00K | 130.00K | 161.00K | 316.00K |
| Earnings from Continuing Operations | -17.39M | -15.16M | -18.44M | -15.19M | -13.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.39M | -15.16M | -18.44M | -15.19M | -13.70M |
| EBIT | -16.04M | -17.44M | -15.36M | -15.01M | -18.76M |
| EBITDA | -14.98M | -16.96M | -14.09M | -13.76M | -17.42M |
| EPS Basic | -0.26 | -0.23 | -0.28 | -0.23 | -0.21 |
| Normalized Basic EPS | -0.16 | -0.14 | -0.17 | -0.14 | -0.13 |
| EPS Diluted | -0.26 | -0.23 | -0.28 | -0.23 | -0.21 |
| Normalized Diluted EPS | -0.16 | -0.14 | -0.17 | -0.14 | -0.13 |
| Average Basic Shares Outstanding | 66.84M | 65.90M | 66.38M | 65.92M | 65.31M |
| Average Diluted Shares Outstanding | 66.84M | 65.90M | 66.38M | 65.92M | 65.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |